Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 5

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 49–60 of 391 articles

Critical impact AnalysisJun 6, 2026

Amneal Romidepsin FDA Approval: B2B Analysis for BD Teams and Investors

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsJun 6, 2026

Listeria Outbreak in Soft Cheese: FDA Investigation and Industry Impact

FDA · Listeria monocytogenes infections · 4 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

FDA Flavored Vape Ban: Youth Risk and Pharma Implications

FDA · 4 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

Listeria Outbreaks 2026: FDA and CDC Soft Cheese Recall Analysis for Pharma

FDA · oncology · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

5 Notable Oncology FDA Approvals Granted in May: A B2B Analysis

FDA · oncology · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

Weekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN

FDA · IgAN · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

The FDA Amendments Act And Drug Safety: Twenty Years Later

FDA · 5 min

Dr. Sarah Mitchell
Critical impact NewsJun 6, 2026

FDA Issues June 2026 Guidance: Gene Therapy, Payor Comms, and CMC Flexibilities

FDA · 4 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

May 2026 FDA Oncology Actions: 8 Approvals Reshape the Landscape

FDA · oncology · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

FDA clears U.S. trial of MAIA lung cancer drug for third-line patients

FDA · lung cancer · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 6, 2026

Pharma bets on PD-1/VEGF bispecifics: Is lung cancer the wrong target?

FDA · non-small cell lung cancer · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 5, 2026

STAT+: What stripping civil service protections for thousands of federal workers will mean for HHS

FDA · 5 min

Dr. Sarah Mitchell